广西医学
廣西醫學
엄서의학
GUANGXI MEDICAL JOURNAL
2014年
11期
1553-1556
,共4页
唐爽%林灿洁%李素芳%钟声学%邓文忠%韦云喜
唐爽%林燦潔%李素芳%鐘聲學%鄧文忠%韋雲喜
당상%림찬길%리소방%종성학%산문충%위운희
局部晚期鼻咽癌%放疗%交替化疗方案%综合疗法
跼部晚期鼻嚥癌%放療%交替化療方案%綜閤療法
국부만기비인암%방료%교체화료방안%종합요법
Locally advanced nasopharyngeal carcinoma%Radiotherapy%Alternating chemotherapy%Comprehensive therapy
目的:观察交替化疗方案加放疗治疗局部晚期鼻咽癌临床疗效、毒副反应。方法128例初治Ⅲ、Ⅳa期鼻咽癌患者随机分为2组,每组64例,放化组:在放疗的第1天开始给予DDP+5-Fu化疗1周期,第29天给予 CBDCA +BLM 化疗1周期;单放组:给予单纯放疗。结果疗程结束时,鼻咽病灶消退率为95.31%,高于单放组的76.56%( P <0.01),颈部淋巴结转移灶消退率放化组为98.43%,高于单放组的87.50%(P<0.01);放化组1、3、5年生存率分别为96.88%、76.56%、54.69%,单放组为90.63%、45.31%、32.81%,两组比较差异有统计学意义( P<0.05)。早期毒副反应:恶心呕吐、口咽黏膜反应和白细胞减少发生率放化组较单放组高且重。远期并发症两组相似。结论交替化疗方案加放疗可提高局部晚期鼻咽癌的肿瘤消退率和5年生存率,早期毒副反应发生率高且重,但均能耐受。
目的:觀察交替化療方案加放療治療跼部晚期鼻嚥癌臨床療效、毒副反應。方法128例初治Ⅲ、Ⅳa期鼻嚥癌患者隨機分為2組,每組64例,放化組:在放療的第1天開始給予DDP+5-Fu化療1週期,第29天給予 CBDCA +BLM 化療1週期;單放組:給予單純放療。結果療程結束時,鼻嚥病竈消退率為95.31%,高于單放組的76.56%( P <0.01),頸部淋巴結轉移竈消退率放化組為98.43%,高于單放組的87.50%(P<0.01);放化組1、3、5年生存率分彆為96.88%、76.56%、54.69%,單放組為90.63%、45.31%、32.81%,兩組比較差異有統計學意義( P<0.05)。早期毒副反應:噁心嘔吐、口嚥黏膜反應和白細胞減少髮生率放化組較單放組高且重。遠期併髮癥兩組相似。結論交替化療方案加放療可提高跼部晚期鼻嚥癌的腫瘤消退率和5年生存率,早期毒副反應髮生率高且重,但均能耐受。
목적:관찰교체화료방안가방료치료국부만기비인암림상료효、독부반응。방법128례초치Ⅲ、Ⅳa기비인암환자수궤분위2조,매조64례,방화조:재방료적제1천개시급여DDP+5-Fu화료1주기,제29천급여 CBDCA +BLM 화료1주기;단방조:급여단순방료。결과료정결속시,비인병조소퇴솔위95.31%,고우단방조적76.56%( P <0.01),경부림파결전이조소퇴솔방화조위98.43%,고우단방조적87.50%(P<0.01);방화조1、3、5년생존솔분별위96.88%、76.56%、54.69%,단방조위90.63%、45.31%、32.81%,량조비교차이유통계학의의( P<0.05)。조기독부반응:악심구토、구인점막반응화백세포감소발생솔방화조교단방조고차중。원기병발증량조상사。결론교체화료방안가방료가제고국부만기비인암적종류소퇴솔화5년생존솔,조기독부반응발생솔고차중,단균능내수。
Objective To observe the clinical effects and toxic reaction of alternating chemotherapy plus radiotherapy for locally advanced nasopharyngeal carcinoma .Methods One hundred and twenty-eight patients with nasopharyngeal carcinoma stageⅢtoⅣa were randomly allocated into two groups,with 64 cases in each group.The concurrent group received one cycle of concurrent chemotherapy with cisplatin plus fluorouracil on the first day of radiotherapy ,and then received another cycle of concurrent chemotherapy with carboplatin plus bleomycin on the twenty-ninth day.The radiotherapy group received radiotherapy alone.Results At the end of treatment ,the complete remission rate of the nasopharynx lesions in the concurrent group was significantly higher than that in the radiotherapy group (95.31% vs.76.56%,P<0.01),and the complete remission rate of the cervical metastatic lymph nodes in the concurrent group was higher than that in the radiotherapy group (98.43%vs.87.50%,P<0.01).The 1-,3-,5-year survival rates were 96.88%,76.56%,54.69% in the concurrent group,respectively,and 90.63%,45.31%,32.81%in the radiotherapy group,respectively,there were significant differences between two groups(P<0.05).The concurrent group had more and severer early toxic reactions such as nausea,vomiting, mucositis and leukopenia compared with radiotherapy group .But the two groups had similar long-term complications . Conclusion Alternating chemotherapy plus radiotherapy can improve the complete remission rate and 5-year survival rate of locally advanced nasopharyngeal carcinoma .It is tolerated,though it has more and severer early toxic reactions .